文献速递头颈外科

肌肉减少症可能预测头颈癌患者复发

Sarcopenia may predict recurrence in patients with head and neck cancer.
PubMed 文献 · Head Neck · 2024-08-13

低SMI患者复发率为26%,显著高于无低SMI患者的2%(p=0.02)。低SMI与更高的复发率强相关。

要点

  • 低SMI患者复发率为26%,无低SMI患者为2%,差异有统计学意义(p=0.02)。
  • 低SMI患者总生存率为72.5%,正常SMI患者为81%,差异无统计学意义(p=0.09)。
  • 第三颈椎水平SMI定义的肌肉减少症与头颈癌复发强相关。

核心结论

  • 以第三颈椎水平低骨骼肌指数定义的肌肉减少症与头颈癌患者更高的复发率强相关。

研究设计与样本

  • 所有患者均有治疗前影像可用于测量第三颈椎水平的骨骼肌指数(SMI)。
  • 肌肉减少症定义:女性SMI < 41 cm2/m2;体重过轻或健康体重男性SMI < 43 cm2/m2;超重或肥胖男性SMI < 53 cm2/m2。

主要发现

  • 肿瘤主要位于口腔(24.1%)和口咽(42%),69.6%的患者接受了手术。
  • 治疗前平均体重指数为28。
  • 队列中69例(61.6%)患者SMI偏低。
  • 平均随访时间为3.9 ± 2.2年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Malnutrition is a major consequence of head and neck cancer (HNC), often leading to decreased skeletal muscle mass and impacting survival. The goal of this study is to determine the effect of sarcopenia, as defined by skeletal muscle index (SMI), on survival in patients with HNC. METHODS: This is a retrospective review of patients with HNC treated with surgery and/or radiation at a single tertiary care institute. All had pre-treatment imaging available for skeletal muscle index (SMI) measurements, and SMI was calculated at the level of the 3rd cervical vertebra. Sarcopenia was defined as an SMI < 41 cm2/m2 in females and as <43 cm2/m2 in underweight or healthy weight males. Sarcopenia was defined as <53 cm2/m2 in overweight or obese males. Chi-square analysis was performed to compare recurrence and survival rates, and survival analysis was performed via Kaplan-Meir curve. RESULTS: Hundred and twelve patients with HNC were evaluated, 84 men and 28 women with an average age of 60.9 years. Tumors were primarily located in the oral cavity (24.1%) and oropharynx (42%). The majority (69.6%) underwent surgery. Mean body mass index prior to treatment was 28. Sixty-nine patients (61.6%) in our cohort had low SMI. Mean follow-up was 3.9 ± 2.2 years. Recurrence rate was 26% in those with low SMI versus 2% in those without. Patients with low SMI were more likely to have a recurrence (p = 0.02). Overall survival was 72.5% in those with low SMI and 81% in those with normal SMI (p = 0.09). CONCLUSIONS: Defining sarcopenia as a low skeletal muscle index at the third cervical vertebra is clinically relevant. This study demonstrates that low SMI at this level, and thus sarcopenia, was strongly associated with higher rates of recurrence.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Colback AA, Arkfeld DV, Paydar A, et al. Sarcopenia may predict recurrence in patients with head and neck cancer. Head Neck. 2024. PMID: 39138607. doi:10.1002/hed.27903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。